PRIX GALIEN KOREA
A Landmark First Edition for Prix Galien Korea, Marking a New Chapter for Korea’s Global Health Community
On September 10, Prix Galien Korea made its debut in Seoul alongside the World Knowledge Forum, bringing together leading voices from research, industry, regulatory bodies, and government for The Inaugural Galien Forum Korea. The event provided a unique platform for dialogue and collaboration around the future of global health, innovation, and scientific excellence. The first-ever Prix Galien Korea Awards then celebrated some of Korea’s most exciting contributions to global health, highlighting the research, innovation, and breakthroughs shaping the future of healthcare.
Prix Galien Korea 2026 Laureates
Best Pharmaceutical Product
Oscotec Inc. for Lazertinib
Yuhan Corporation for Leclaza® (Lazertinib mesylate)
Best Biotechnology Product
Alteogen Inc. for TERGASE®
Best Medical Technology
BIONEER Corporation for ExiStation™ FA 96 / Fully-Automated Molecular Diagnostics Platform
Best Digital Health Solution
Dot Inc. for Dot Pad X
Best Startup
ADEL Inc.
“The Prix Galien is the right event, on the right issue at the right time. I thank the Galien Foundation for bringing us together and for recognizing that a healthier world is a safer world and a more just world.”
- Ban Ki-moon, UN Secretary-General at the 2010 Prix Galien USA Awards Ceremony
The inaugural Galien Korea Forum brought together leading voices from research, industry, regulatory bodies, and government, creating a unique platform for exchange and collaboration around the future of global health. Held alongside the World Knowledge Forum on September 10, 2026, the Forum set the stage for the first edition of the Prix Galien Korea.
The first edition of the Prix Galien Korea honored the most exciting innovations in the life sciences, recognizing the teams behind life-changing drugs, biologics, technologies, methodologies, and digital solutions. As an honor of the highest order for research, development, and the distribution of innovations improving the human condition, the Prix Galien celebrated Korea’s contribution to the global health community.
Prix Galien Korea Awards Committee
A prestigious committee comprising eight of the finest distinguished researchers in their fields will be chaired by Professor Park Yeong Min, MD. The committee will judge submissions to the inaugural prize in the categories Best Biotechnology Product, Best Digital Health Solution, Best Medical Technology, Best Pharmaceutical Product, and Best Startup.
Park Yeong Min, MD, PhD (Committee Chair)
Byoung Chul Cho, MD, PhD
Taeghwan Hyeon, PhD
Hail Kim, MD, PhD
Yeul Hong Kim, MD, PhD
Beop-Min Kim, PhD
Inee Mook-Jung, PhD
Byung Geon Rhee, PhD
“The Prix Galien is a welcome initiative to stimulate creative research and promote excellence.”
- Barack Obama, President of the United States – 2008
“The Prix Galien USA recognizes the important research necessary to develop innovative medicines and devices that have a lifesaving impact on individuals and families across the globe.”
- Kathleen Sebelius, Former US Secretary of Health and Human Services
“I welcome you to the annual Prix Galien awards for innovative excellence in biomedical products and health technologies. The awards are among the highest honors in science and commerce.”
- Jimmy Carter, US PresidentThe inaugural edition of the Prix Galien Korea is co-hosted in collaboration with:

